Gerald E. Metter

963 total citations
21 papers, 772 citations indexed

About

Gerald E. Metter is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Gerald E. Metter has authored 21 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Gerald E. Metter's work include Cancer Treatment and Pharmacology (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Gerald E. Metter is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Gerald E. Metter collaborates with scholars based in United States. Gerald E. Metter's co-authors include Cary A. Presant, James A. Lipsett, Geraldine Padilla, Frances Heide, Marcia Grant, Clarence C. Whitcomb, Jerome S. Burke, Risa B. Mann, Thomas P. Miller and Maurice Barcos and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Transplantation.

In The Last Decade

Gerald E. Metter

20 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald E. Metter United States 14 395 156 148 115 114 21 772
Peter Reese United States 12 172 0.4× 104 0.7× 51 0.3× 78 0.7× 100 0.9× 21 477
G. R. Langley Canada 16 165 0.4× 70 0.4× 127 0.9× 69 0.6× 104 0.9× 38 879
John Coombs United States 17 289 0.7× 150 1.0× 107 0.7× 102 0.9× 140 1.2× 45 1.4k
Anni Ravnsbæk Jensen Denmark 15 557 1.4× 265 1.7× 220 1.5× 250 2.2× 54 0.5× 24 1.2k
S. Klapper United States 5 561 1.4× 327 2.1× 83 0.6× 157 1.4× 199 1.7× 7 1.3k
Audrey A. Dawson United Kingdom 19 252 0.6× 169 1.1× 183 1.2× 182 1.6× 97 0.9× 77 1.1k
Nehal Masood Pakistan 14 341 0.9× 201 1.3× 80 0.5× 82 0.7× 39 0.3× 35 617
Noel S. Weiss United States 22 573 1.5× 316 2.0× 143 1.0× 221 1.9× 263 2.3× 32 1.4k
Steven A. Kuross United States 15 786 2.0× 368 2.4× 32 0.2× 235 2.0× 75 0.7× 19 1.4k
Haoling H. Weng United States 17 147 0.4× 195 1.3× 59 0.4× 140 1.2× 88 0.8× 32 1.5k

Countries citing papers authored by Gerald E. Metter

Since Specialization
Citations

This map shows the geographic impact of Gerald E. Metter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald E. Metter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald E. Metter more than expected).

Fields of papers citing papers by Gerald E. Metter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald E. Metter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald E. Metter. The network helps show where Gerald E. Metter may publish in the future.

Co-authorship network of co-authors of Gerald E. Metter

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald E. Metter. A scholar is included among the top collaborators of Gerald E. Metter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald E. Metter. Gerald E. Metter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carr, Brian I., Douglas W. Blayney, David A. Goldberg, et al.. (1987). High doses of prochlorperazine for cisplatin-induced emesis: A prospective, random, dose–response study. Cancer. 60(9). 2165–2169. 19 indexed citations
2.
Presant, Cary A., et al.. (1987). Reversal of cancer chemotherapeutic resistance by amphotericin B—A broad phase I–II pilot study. European Journal of Cancer and Clinical Oncology. 23(6). 683–687. 13 indexed citations
3.
Ellison, Douglas J., Bharat N. Nathwani, Gerald E. Metter, et al.. (1987). Mitotic counts in follicular lymphomas. Human Pathology. 18(5). 502–505. 20 indexed citations
4.
Blume, Karl G., Stephen J. Forman, David S. Snyder, et al.. (1987). ALLOGENEIC BONE MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA DURING FIRST COMPLETE REMISSION. Transplantation. 43(3). 389–392. 66 indexed citations
5.
Bertrand, M, James H. Doroshow, Douglas W. Blayney, et al.. (1986). High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.. Journal of Clinical Oncology. 4(7). 1058–1061. 37 indexed citations
6.
Metter, Gerald E., et al.. (1985). Survival of cancer patients by economic status in a free care setting. Cancer. 55(7). 1552–1555. 35 indexed citations
7.
Metter, Gerald E., Bharat N. Nathwani, Jerome S. Burke, et al.. (1985). Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies.. Journal of Clinical Oncology. 3(1). 25–38. 108 indexed citations
8.
9.
10.
Presant, Cary A., Gerald E. Metter, M Bertrand, et al.. (1984). Effects of amphotericin B with combination chemotherapy on response rates and on survival in non-small cell carcinoma of the lung.. PubMed. 68(4). 651–4. 7 indexed citations
11.
Padilla, Geraldine, Cary A. Presant, Marcia Grant, et al.. (1983). Quality of Life Index for Patients with Cancer. Research in Nursing & Health. 6(3). 117–126. 250 indexed citations
12.
Shively, John E., et al.. (1982). Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.. PubMed. 42(6). 2506–13. 15 indexed citations
13.
Presant, Cary A., et al.. (1980). Chemotherapy of advanced prostatic cancer with adriamycin, BCNU, and cyclophosphamide. Cancer. 46(11). 2389–2392. 7 indexed citations
14.
Cruz, Anatolio B., J. Bradley Aust, Gerald E. Metter, et al.. (1979). Combination chemotherapy for soft‐tissue sarcomas: A phase III study. Journal of Surgical Oncology. 11(4). 313–323. 32 indexed citations
15.
Metter, Gerald E., H. Stephens Moseley, William Kraybill, et al.. (1978). Adriamycin, bleomycin, and CCNU as effective induction chemotherapeutic agents in advanced squamous cell carcinoma (COG protocol 7333). Journal of Surgical Oncology. 10(6). 501–509.
16.
Metter, Gerald E., et al.. (1977). Importance of microscopic vascular invasion in primary cutaneous malignant melanoma.. PubMed. 145(4). 559–61. 12 indexed citations
17.
Grage, Theodor B., Gerald E. Metter, George N. Cornell, et al.. (1977). Adjuvant chemotherapy with 5-fluorouracil after surgical resection of colorectal carcinoma (COG protocol 7041). The American Journal of Surgery. 133(1). 59–66. 27 indexed citations
18.
Metter, Gerald E., et al.. (1976). Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(2). 183–7. 35 indexed citations
19.
Metter, Gerald E., et al.. (1976). Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?. PubMed. 142(6). 882–92. 6 indexed citations
20.
Cruz, Anatolio B., Gerald E. Metter, J. Bradley Aust, et al.. (1976). Treatment of advanced malignancy with ccnu (nsc 79037).A phase II cooperative study with long-term follow up. Cancer. 38(3). 1069–1076. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Reese Breakdown of academic impact, for papers by G. R. Langley Breakdown of academic impact, for papers by John Coombs Breakdown of academic impact, for papers by Anni Ravnsbæk Jensen Breakdown of academic impact, for papers by S. Klapper Breakdown of academic impact, for papers by Audrey A. Dawson Breakdown of academic impact, for papers by Nehal Masood Breakdown of academic impact, for papers by Noel S. Weiss Breakdown of academic impact, for papers by Steven A. Kuross Breakdown of academic impact, for papers by Haoling H. Weng
Rankless by CCL
2026